Rep. Kevin Hern (R-Okla.) has disclosed a sale of Medtronic plc Ordinary Shares (MDT) in a new Periodic Transaction Report filed with the U.S. House of Representatives. The transaction, made through a jointly-held account with his spouse and held via the Hern Family Foundation, took place on 2026-08-24. The disclosed value falls between $15,001 and $50,000, and whoisbuyingnow.com classifies this as a congress sale.
Under the STOCK Act, members of Congress and their spouses are required to publicly report transactions like this one within a set window after execution. The filing does not include any explanation for the sale, and disclosure of this kind is a routine legal obligation rather than an indication of wrongdoing or insider knowledge.
An Insider Sale in the Same Window
What makes this filing notable is its timing relative to activity inside Medtronic itself. Company insider Marinaro Michael also sold MDT shares on 2026-08-20, in a transaction valued at $100,053, just days before Hern’s own reported sale and within the same 30-day window. Two separate disclosures involving the same stock, coming from different reporting regimes, is the kind of overlap whoisbuyingnow.com tracks closely as part of its broader pattern coverage of Medtronic-related trading activity.
Congressional trading in MDT has drawn attention before. Earlier this year, whoisbuyingnow.com covered Rep. Richard McCormick’s sale of Medtronic stock in a Roth IRA, another instance of a House member offloading shares in the medical device maker. Taken together with Hern’s latest filing and the insider transaction from Marinaro Michael, Medtronic has become a recurring name in disclosure activity tracked across both congressional and corporate filings.
What the Filing Does and Doesn’t Show
The report confirms the sale occurred, the account structure involved, the date, and the disclosed dollar range, nothing more. It does not indicate the reasoning behind the sale, whether it was part of a broader portfolio rebalancing tied to the Hern Family Foundation, or how it relates, if at all, to the insider transaction noted above. Readers interested in how these disclosures compare across different types of filers, including institutional and fund-level activity, can also see how whoisbuyingnow.com’s Veritas Asset Management LLP portfolio tracker approaches similar quarterly reporting patterns.
Whoisbuyingnow.com will continue monitoring subsequent STOCK Act filings and insider transaction reports involving Medtronic to determine whether this cluster of activity reflects an isolated coincidence or a more sustained pattern worth following.